Monday, 3 June 2013

ASCO '13: Amgen's Cancer-Killing Virus Shows Skin-Cancer Survival Trend (Update)

ASCO '13: Amgen's Cancer-Killing Virus Shows Skin-Cancer Survival Trend 

TheStreet.com 
PD-1 refers to the drugs being developed by Bristol-Myers, Merck and Roche. "We're doing early safety studies, it's too early to comment but the interest in pursuing this approach is much higher today." In the Amgen phase III trial, more than 400 ... 

http://www.thestreet.com/story/11938587/1/asco-13-amgens-cancer-killing-virus-shows-skin-cancer-survival-trend.html?cm_ven=GOOGLEN


by world drug tracker
DR ANTHONY MELVIN CRASTO

No comments:

Post a Comment